Generic Name and Formulations:
Levothyroxine sodium 25mcg, 50mcg (dye-free), 75mcg, 88mcg, 100mcg, 112mcg, 125mcg, 150mcg, 175mcg, 200mcg, 300mcg; scored tabs.
Jerome Stevens Pharmaceuticals, Inc.
Indications for UNITHROID:
Take in AM on empty stomach. Hypothyroidism: 1.7mcg/kg once daily. >50yrs, or <50yrs with cardiovascular disease: initially 25–50mcg once daily; titrate in increments of 12.5–25mcg every 4–6 weeks. Elderly with cardiovascular disease: initially 12.5–25mcg once daily; titrate in increments of 12.5–25mcg every 4–6 weeks. Usual max 200mcg/day. Severe hypothyroidism: initially 12.5–25mcg once daily; titrate in increments of 25mcg/day every 4 weeks. Subclinical hypothyroidism, secondary or tertiary hypothyroidism: see literature.
Give once daily on empty stomach. May crush tabs and mix in 5–10mL water. Hypothyroidism: 0–3months: 10–15mcg/kg per day; 3–6months: 8–10mcg/kg per day; 6–12months: 6–8mcg/kg per day; 1–5yrs: 5–6mcg/kg per day; 6–12yrs: 4–5mcg/kg per day; >12yrs: 2–3mcg/kg per day; growth and puberty complete: as adult. Chronic or severe hypothyroidism: initially 25mcg/day; titrate in increments of 25mcg every 4weeks. Infants with serum T4<5mcg/dL: initially 50mcg/day.
Uncorrected adrenal insufficiency. Untreated thyrotoxicosis. Acute MI.
Not for treatment of obesity or infertility. Cardiovascular disease. Seizures. Adrenocortical insufficiency. Increased sensitivity in severe hypothyroidism. Autonomous thyroid tissue. Myxedema coma: use IV levothyroxine. Elderly. Pregnancy (Cat. A); do not discontinue due to pregnancy. Nursing mothers.
See literature. Absorption reduced by some foods (e.g., soy, fiber), aluminum and magnesium hydroxide, simethicone, calcium carbonate, sodium polystyrene sulfonate, bile acid sequestrants, iron, sucralfate (give at least 4 hrs apart). Potentiates, and is potentiated by, tri- and tetracyclic antidepressants, sympathomimetics. Antagonized by hepatic enzyme inducers (e.g., carbamazepine, phenytoin, phenobarbital, rifampin), sertraline. Antagonizes digoxin. Marked hypertension and tachycardia with ketamine. Estrogens affect thyroid function tests. Monitor oral anticoagulants, antidiabetic agents, theophylline.
Hyperthyroidism, decreased bone mineral density, transient alopecia; seizures (rare); pseudotumor cerebri in children.
Sign Up for Free e-newsletters
Regimen and Drug Listings
GET FULL LISTINGS OF TREATMENT Regimens and Drug INFORMATION
|Head and Neck Cancer||Regimens||Drugs|
|Renal Cell Carcinoma||Regimens||Drugs|
Cancer Therapy Advisor Articles
- Immune Checkpoint Inhibitors for NSCLC: Current and Future Approaches
- Clostridium Difficile Infection in Patients With Cancer — In the Clinic
- Can A Consortium of Hospitals Help To Reduce Drug Prices?
- Erdafitinib Granted FDA Breakthrough Therapy Designation for Urothelial Carcinoma
- NSCLC: Stratifying Patients With Complex EGFR Mutations
- Nivolumab Plus Ipilimumab Improves Overall Survival, ORR in Renal Cell Carcinoma
- Encorafenib, Binimetinib May Be Effective in BRAF-Mutant Melanoma
- CLL: Venetoclax Plus Rituximab Improves 2-Year PFS
- Confronting Racial Disparities in Prostate Cancer Survival Outcomes
- FDA Approves Front-Line Brentuximab Vedotin Plus Chemotherapy for Hodgkin Lymphoma